EUCTR2020-004931-25-FIActive, not recruitingPhase 1
Intranasal dexmedetomidine pharmacokinetics on patients under general anesthesia
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Turku University Hospital
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. The patient is scheduled for elective unilateral total knee arthroplasty (TKA) or hip arthroplasty (THA) under general anesthesia
- •2. Fluent skills in finnish language (to understand the given information and to be able to give informed consent and communicate with the study personnel)
- •3. Age between 35 and 80 years
- •4. Weight between 50 and 100 kg
- •5. ASA (American Society of Anesthesiologists) status 1-3
- •6. Written informed consent from the patient
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
Exclusion Criteria
- •1. A previous history of intolerance to the study drug or related compounds and additives
- •2. Disease or condition affecting patient’s ability to give written informed consent
- •3. Existing or recent significant disease possible affecting absorption, distribution, metabolism, excretion or response to the study drug
- •4. History of cardiac disease (valvular insufficiency, severe left ventricular dysfunction) or abnormal ECG rhythm (bradycardia < 50/min, 2nd or 3rd degree AV-block, pacemaker)
- •5. Chronic opioid use or use of other analgesic adjuvants such as pregabalin, gabapentin, amitriptyline or duloxetine
- •6. Participation in any other study concomitantly or within one month prior to the entry into this study
- •7. Clinically significant abnormal findings in physical examination or laboratory screening
- •8. Use of drugs or natural products known to cause enzyme induction or inhibition
- •9. Pregnancy or breastfeeding
- •10. Spinal anesthesia
Investigators
Similar Trials
Active, not recruiting
Phase 1
Intransal pharmacokinetics of dexmedetomidine in preterm newbornsPreterm newborns of less than/or equal to 36 weeks of gestational age who have an umbilical venous or arterial catheter which, for nutritional and/or therapeutic needs, must be replaced by a percutaneous central venous catheter (PICC).MedDRA version: 21.1Level: LLTClassification code 10049124Term: Sedation during medical procedureSystem Organ Class: 100000004865EUCTR2021-000801-25-ITIRCCS MATERNO INFANTILE BURLO GAROFOLO10
Completed
Phase 4
Comparison of Dexmedetomidine and Midazolam as Intanasal Premedication in ChildreCTRI/2018/03/012807Principle Investigator104
Completed
Not Applicable
A COMPARATIVE STUDY OF INTRANASAL DEXMEDETOMIDINE AND INTRANASAL MIDAZOLAM FOR PREMEDICATION IN CHILDREN POSTED FOR TONSILLECTOMYCTRI/2021/07/034831Sri Manakula Vinayagar Medical College and Hospital100
Not yet recruiting
Phase 1
Study to compare a drug named Dexmedetomidine which will be given in nose and a syrup named triclofos sodium which will be given per mouth in children as prior medicine before CT ScaCTRI/2019/07/020243Institute of Post Graduate Medical Education Research
Not yet recruiting
Unknown
To compare the effects of dexmedetomidine and ketamine in children undergoing procedure for congenital heart diseaseCTRI/2023/04/052005Vardhman Mahavir Medical College and Safdarjung Hospital